Literature DB >> 30613635

Dasatinib in breast cancer: Src-ing for response in all the wrong kinases.

Laura C Kennedy1,2, Vijayakrishna Gadi1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30613635      PMCID： PMC6291560          DOI： 10.21037/atm.2018.10.26

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  6 in total

1.  Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development.

Authors:  Stephen F Madden; Mattia Cremona; Angela M Farrelly; Weng Hei Low; Jean McBryan
Journal:  Cancer Gene Ther       Date:  2022-10-20       Impact factor: 5.854

2.  Identification of a Triple Drug Combination That Is Synergistically Cytotoxic for Triple-Negative Breast Cancer Cells Using a Novel Combination Discovery Approach.

Authors:  Syed Ahmad; Qingping He; Kevin P Williams; John E Scott
Journal:  SLAS Discov       Date:  2020-05-22       Impact factor: 3.341

Review 3.  Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy.

Authors:  Miguel Angel Galván Morales; Raúl Barrera Rodríguez; Julio Raúl Santiago Cruz; Luis M Teran
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

4.  Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment.

Authors:  John C Dawson; Alison Munro; Kenneth Macleod; Morwenna Muir; Paul Timpson; Robert J Williams; Margaret Frame; Valerie G Brunton; Neil O Carragher
Journal:  Mol Oncol       Date:  2021-12-18       Impact factor: 6.603

5.  Effects of Lidocaine and Src Inhibition on Metastasis in a Murine Model of Breast Cancer Surgery.

Authors:  Thomas P Wall; Peter D Crowley; Aislinn Sherwin; Andrew G Foley; Donal J Buggy
Journal:  Cancers (Basel)       Date:  2019-09-22       Impact factor: 6.639

6.  Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.

Authors:  Li Li; Ling Lin; Jamunarani Veeraraghavan; Yiheng Hu; Xian Wang; Sanghoon Lee; Ying Tan; Rachel Schiff; Xiao-Song Wang
Journal:  Breast Cancer Res       Date:  2020-08-08       Impact factor: 6.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.